XML 59 R42.htm IDEA: XBRL DOCUMENT v3.8.0.1
Restructuring Charges and Other Costs Associated with Acquisitions and Cost-Reduction/Productivity Initiatives - Footnotes (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Oct. 01, 2017
Oct. 02, 2016
Oct. 01, 2017
Oct. 02, 2016
Restructuring Cost and Reserve [Line Items]        
Provision [1] $ 91 $ 404 $ 150 $ 574
Corporate [Member]        
Restructuring Cost and Reserve [Line Items]        
Provision 25 67 51 107
IH [Member] | Operating Segments [Member]        
Restructuring Cost and Reserve [Line Items]        
Provision 4 148 10 162
EH [Member] | Operating Segments [Member]        
Restructuring Cost and Reserve [Line Items]        
Provision 1 28 (9) 19
WRD & GPD [Member] | Segment Reconciling Items [Member]        
Restructuring Cost and Reserve [Line Items]        
Provision 15 52 29 104
Manufacturing operations [Member] | Segment Reconciling Items [Member]        
Restructuring Cost and Reserve [Line Items]        
Provision 47 108 70 181
Pension Plan [Member] | U.S. [Member] | Qualified [Member]        
Restructuring Cost and Reserve [Line Items]        
Net gain related to the settlement $ (30) $ (21) (54) [2] $ (52) [2]
Hospira [Member] | Pension Plan [Member] | U.S. [Member] | Qualified [Member]        
Restructuring Cost and Reserve [Line Items]        
Net gain related to the settlement     $ 12  
[1] In the third quarter and first nine months of 2017, restructuring charges are primarily associated with our acquisitions of Hospira and Medivation, as well as cost-reduction and productivity initiatives not associated with acquisitions. In the third quarter and first nine months of 2016, restructuring charges are largely associated with cost-reduction and productivity initiatives not associated with acquisitions, as well as our acquisitions of Hospira and Medivation. In the third quarter and first nine months ended October 1, 2017, Employee terminations primarily include revisions of our estimates of severance benefits. Employee termination costs are generally recorded when the actions are probable and estimable and include accrued severance benefits, pension and postretirement benefits, many of which may be paid out during periods after termination.
The restructuring activities for 2017 are associated with the following:
•
For the third quarter of 2017, IH ($4 million); EH ($1 million); WRD/GPD ($15 million); manufacturing operations ($47 million); and Corporate ($25 million).
•
For the first nine months of 2017, IH ($10 million); EH ($9 million income); WRD/GPD ($29 million); manufacturing operations ($70 million); and Corporate ($51 million).
The restructuring activities for 2016 are associated with the following:
•
For the third quarter of 2016, IH ($148 million); EH ($28 million); WRD/GPD ($52 million); manufacturing operations ($108 million); and Corporate ($67 million).
•
For the first nine months of 2016, IH ($162 million); EH ($19 million); WRD/GPD ($104 million); manufacturing operations ($181 million); and Corporate ($107 million).
[2] In April 2017, we settled the remaining obligation associated with the Hospira U.S. qualified defined benefit pension plan. We purchased a group annuity contract on behalf of the remaining plan participants with a third-party insurance provider. As a result, we were relieved of the $156 million net pension benefit obligation and recorded a pretax settlement gain of $41 million, partially offset by the recognition of actuarial losses and prior service costs upon plan settlement of approximately $30 million in Restructuring charges and certain acquisition-related costs during the second quarter of 2017 (see Note 3).